Is there a role for RDTs as we live with COVID-19? An assessment of different strategies
Introduction By 2022, high levels of past COVID-19 infections, combined with substantial levels of vaccination and the development of Omicron, have shifted country strategies towards burden reduction policies. SARS-CoV-2 rapid antigen tests (rapid diagnostic tests (RDTs)) could contribute to these p...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2023-01-01
|
| Series: | BMJ Global Health |
| Online Access: | https://gh.bmj.com/content/8/1/e010690.full |